[Complications of the treatment of rheumatoid arthritis with chrysanol].
Gorokhovskaia
G N
GN
Kozhurin
S V
SV
Fedotenkov
S A
SA
Omel'ianenko
N M
NM
Kriuchkova
L S
LS
D000741:Anemia, Aplastic / Q000139:chemically induced*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004112:Dimercaprol / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008667:Metalloproteins / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D013997:Time Factors
D018501:Antirheumatic Agents; D008667:Metalloproteins; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; C013394:aurotioprol
Oslozhneniia pri lechenii revmatoidnogo artrita krizanolom.